Patient Perspectives Following a One-Week Medication Washout in Early-Stage Parkinson’s Disease Patients
Brain Sciences · 20.11.2026 · 16 (11) · 1277
DOI: 10.3390/brainsci16111277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 20.11.2026. Verfasst von Owen Dong und 13 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute on Aging, Consolidated Anti-Aging Foundation, NCATS/NIH.
Abstract (Originalsprache)
Background/Objectives: Therapeutic washout protocols, where Parkinson’s disease (PD) patients discontinue their medication, are used in clinical trials to evaluate disease progression without the overt influence of symptomatic treatments. While prior washout studies focused on clinical outcomes, the participant experiences of undergoing an extended washout have not been examined. This study characterizes early-stage PD participants’ expectations, symptom experiences, emotional responses, and reflections following a one-week medication washout.
Methods
Twenty early-stage PD participants enrolled in a one-week washout study (15 M/5 F; aged 65.7 ± 6.7 years; medication duration 1.8 ± 0.8 years; LEDD 490 ± 414 mg). Semi-structured interviews (~1 h) were audio-recorded, transcribed, and coded by trained coders. Transcripts were analyzed using an inductive–deductive approach to identify common themes and develop a conceptual framework.
Results
All 20 participants were interviewed, including one who withdrew on day 5 due to intolerable symptoms. Recalled expectations ranged from confidence to fear of symptom exacerbation, and reassurance from study personnel reduced pre-washout anxiety. Symptoms included sleep disruption, restless legs symptoms, stiffness, tremor, and progressive motor decline that often intensified in the latter half of the week. Emotional responses ranged from frustration and isolation to equanimity. Upon resuming medications, recovery timelines varied. Many participants gained new insight into their medication’s efficacy, and some perceived their unmedicated state as a glimpse of how they might function as their disease progresses.
Conclusions
This study provides the first characterization of participant experiences following a one-week medication washout in early-stage PD. These perspectives can inform washout protocol design, participant support, and retention in future clinical trials.
Förderung
- National Institute on Aging
- Consolidated Anti-Aging Foundation
- NCATS/NIH
Zitieren
APA
Dong, O., Tobias, E., Pazira, K., Kling, H., Kopaeva, L., Venditti, L., Nguyen, H., Sharp, S., Davis, T., Cannard, K., Bonnet, K., Schlundt, D., Charles, D., & Hacker, M. (2026). Patient Perspectives Following a One-Week Medication Washout in Early-Stage Parkinson’s Disease Patients. Brain Sciences, 16(11), 1277. https://doi.org/10.3390/brainsci16111277
Vancouver
Dong O, Tobias E, Pazira K, Kling H, Kopaeva L, Venditti L, et al. Patient Perspectives Following a One-Week Medication Washout in Early-Stage Parkinson’s Disease Patients. Brain Sciences. 2026;16(11):1277. doi:10.3390/brainsci16111277
BibTeX
@article{Dong2026,
author = {Dong, Owen and Tobias, Ella and Pazira, Kian and Kling, Haley and Kopaeva, Leeza and Venditti, Liliana and Nguyen, Han and Sharp, Sheffield and Davis, Thomas and Cannard, Kevin and Bonnet, Kemberlee and Schlundt, David and Charles, David and Hacker, Mallory},
title = {Patient Perspectives Following a One-Week Medication Washout in Early-Stage Parkinson’s Disease Patients},
journal = {Brain Sciences},
year = {2026},
volume = {16},
number = {11},
pages = {1277},
doi = {10.3390/brainsci16111277}
}
EUVIMED